What is the appropriate pediatric dosing for Adderall (mixed amphetamine salts) in children with ADHD?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Adderall Pediatric Dosing

For children aged 6 years and older with ADHD, start Adderall at 5 mg once or twice daily, increasing by 5 mg weekly until optimal response is achieved, with a maximum total daily dose of 40 mg. For children aged 3-5 years, start at 2.5 mg daily and increase by 2.5 mg weekly 1.

Age-Specific Starting Doses

Children 6 Years and Older

  • Starting dose: 5 mg once or twice daily (morning after breakfast and noon after lunch) 2, 1
  • Titration: Increase by 5 mg weekly intervals until symptoms are controlled 2
  • Maximum dose: 40 mg total daily dose 2, 1

Children 3-5 Years (Preschool)

  • Starting dose: 2.5 mg daily 1
  • Titration: Increase by 2.5 mg weekly until optimal response 1
  • Important caveat: Adderall is not recommended for children under 3 years 1. For preschool-aged children (4-5 years), methylphenidate is the preferred first-line stimulant over amphetamines due to stronger evidence in this age group 3

Weight-Based Considerations

Children weighing less than 25 kg should not receive single doses greater than 10 mg of amphetamine 2. This is a critical safety threshold to prevent excessive dosing in smaller children.

For the forced titration approach, children weighing less than 45 lb (20 kg) should omit the 15 mg and 20 mg dose weeks during initial titration 2.

Dosing Schedule and Administration

  • First dose: Give upon awakening 1
  • Additional doses: 1-2 additional doses at 4-6 hour intervals 1
  • Typical regimen: Twice daily dosing (morning and noon), though some children may require only once-daily dosing depending on duration of effect 2
  • Avoid late evening doses to prevent insomnia 1

Titration Strategy

Two evidence-based approaches exist:

Standard Stepwise Titration

Increase dose by 2.5-5 mg weekly based on symptom control and tolerability 2. Stop titration when symptoms resolve and impairment diminishes, or when dose-limiting side effects occur.

Forced Titration Trial

Give all four dosages (2.5,7.5,10 mg) with each dose lasting 1 week, then select the dose producing maximum benefit with fewest side effects 2. This approach ensures children don't miss a potentially beneficial higher dose.

Monitoring Requirements

Before initiating treatment:

  • Baseline blood pressure, pulse, height, and weight 2
  • Physical examination to identify cardiac disease 1
  • Assessment for motor/verbal tics or Tourette's syndrome 1

During titration (weeks 1-4):

  • Weekly contact (visit or phone) 2
  • ADHD rating scales from parents and teachers 2
  • Systematic assessment of side effects 2

Maintenance phase:

  • Monthly appointments until symptoms stabilized 2
  • Quarterly blood pressure and pulse checks 2
  • Annual vital signs during routine physical 2
  • Weight at each visit to monitor appetite effects 2

Common Pitfalls to Avoid

Underdosing is common in clinical practice 4, 5. Community treatment data shows mean doses of 11.2-16.5 mg/day for immediate-release amphetamine salts, substantially lower than doses used in clinical trials 4. When titration occurs, it's linked to lower initial dosing and clinical monitoring 4.

Don't assume more is always better. If the maximum recommended dose doesn't help, consider changing medications or adding psychosocial interventions rather than exceeding 40 mg/day 2. While expert consensus allows exceeding PDR limits on rare occasions, this requires clear documentation that symptoms couldn't be controlled at lower doses and higher doses aren't producing side effects 2.

Weight-based dosing is problematic. Standard tablets are unscored, making fractional doses difficult to achieve accurately 2. Fixed-dose titration using whole or half tablets reflects typical U.S. practice and is more practical 2.

Side Effect Profile

Most common treatment-related adverse events include:

  • Decreased appetite (most frequent) 6, 7
  • Insomnia 6, 7
  • Headache 6, 7

These are typically mild and dose-related 7. Interestingly, some symptoms like staring/daydreaming, sadness, and irritability may be rated as worse during placebo regimens 6.

Special Considerations

Growth attenuation: Children on higher doses experience more growth suppression (Δ height z-score -0.41 vs -0.09, Δ weight z-score -0.56 vs -0.18), though this mainly occurs before reaching high-dose range 8. Monitor growth parameters regularly.

Extended-release formulations: Once-daily Adderall XR (10-30 mg) maintains efficacy over 24 months with similar tolerability profile 7. Peak effects occur at approximately 8 hours post-dose with duration extending to 12 hours 9.

Subtherapeutic dosing: A 6.25 mg dose (half the lowest approved adolescent/adult dose) was not superior to placebo in children aged 6-12 years, confirming this dose is subtherapeutic 10.

References

Guideline

practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults.

Journal of the American Academy of Child and Adolescent Psychiatry, 2002

Research

Stimulant dosing for children with ADHD: a medical claims analysis.

Journal of the American Academy of Child and Adolescent Psychiatry, 2009

Research

Long-term tolerability and effectiveness of once-daily mixed amphetamine salts (Adderall XR) in children with ADHD.

Journal of the American Academy of Child and Adolescent Psychiatry, 2005

Research

Analog classroom assessment of a once-daily mixed amphetamine formulation, SLI381 (Adderall XR), in children with ADHD.

Journal of the American Academy of Child and Adolescent Psychiatry, 2003

Related Questions

Can a four-year-old child be started on Adderall (amphetamine salts) for ADHD, and what initial dose and monitoring are recommended?
How should an 11-year-old child be initiated on mixed amphetamine salts (Adderall) for newly presenting ADHD symptoms?
What is the appropriate Adderall XR (mixed amphetamine salts) dosing regimen for a 6‑year‑old child diagnosed with ADHD?
What is the maximum recommended daily dose of Adderall (mixed amphetamine salts) for ADHD and narcolepsy in children, adolescents, and adults?
What is the recommended dosing regimen for Mydayis (mixed amphetamine salts) in patients aged 13 years and older, including starting dose, titration increments, maximum dose, and contraindications?
What are the risks of using a negative‑pressure wound vacuum (NPWT) on a wound with untreated osteomyelitis?
What is the likely cause and appropriate evaluation for a patient with small-caliber stools and colicky abdominal pain without abdominal distention, nausea, or vomiting?
How is colon cancer staged and what are the treatment options for each stage?
Does tirzepatide increase the risk of renal calculi, and what precautions should be taken for patients with a history of kidney stones while using this medication?
Does mifepristone (Korlym) interact with the patient's current medications: eszopiclone (Lunesta), bupropion (Wellbutrin XL), trazodone, atorvastatin, tirzepatide (Zepbound), metoprolol succinate extended‑release, and losartan‑hydrochlorothiazide?
Given my apolipoprotein B level of 114 mg/dL, high low‑density lipoprotein cholesterol, triglycerides of about 210 mg/dL, very low high‑density lipoprotein cholesterol, and an elevated apolipoprotein B/A1 ratio, together with a history of gallstones, use of tirzepatide (Mounjaro), alcohol consumption, and prior elevated amylase/lipase, what immediate lipid‑lowering treatment and monitoring plan should I follow, and how concerned should I be about pancreatitis risk?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.